Wes McConnell

Wes McConnell currently serves as Chief Financial Officer at Ascend Advanced Therapies since July 2022, focusing on the development of high-quality gene therapies. Prior to this role, Wes held the position of Director of Finance at Bavarian Nordic, A/S from December 2010 to July 2022, and briefly served as Director of Government Programs at AstraZeneca during the H1N1 pandemic. Additional experience includes Director of Government Reporting at Bavarian Nordic A/S, Supervisor of International Finance at Hughes Network Systems, and Contracts Administrator at Casals & Associates, Inc. Wes's academic credentials include an MBA in International Business from The George Washington University, a Post Masters Certificate in Accounting, and a Certificate in Essentials of Leadership from London Business School, among other qualifications.